Displaying drugs 501 - 525 of 1069 in total
Homocysteine
Homocysteine is a thiol-containing amino acid formed by a demethylation of methionine.
Experimental
Matched Categories: … Sulfur Compounds ... Amino Acids, Sulfur …
3-(cyclohexylamino)propanesulfonic acid
Experimental
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
Thiocolchicoside
Thiocolchicoside is a semi-synthetic derivative of the colchicine, a natural anti-inflammatory glycoside which originates from the flower seeds of Superba gloriosa. It is a muscle relaxant with anti-inflammatory and analgesic effects. It has potent convulsant activity and should not be administered to individuals prone to seizures.
Experimental
Acediasulfone
Acediasulfone (INN) is an antimicrobial and antimalarial long-acting prodrug of dapsone.
Experimental
Matched Categories: … Sulfur Compounds …
MK-2748
MK-2748 is under investigation in clinical trial NCT01593735 (A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1)).
Investigational
Matched Categories: … Sulfur Compounds …
Chlorfenson
Chlorfenson is developed by Moberg Derma for the treatment of onychomycosis (nail fungus) as the primary indication.
Investigational
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
Tesaglitazar
Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.
Investigational
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
T-900607
T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer.
Investigational
Matched Categories: … Sulfur Compounds …
Vercirnon
Vercirnon is a novel, orally active anti-inflammatory agent that targets a chemokine receptor protein implicated in both Crohn's disease and ulcerative colitis, the two principal forms of IBD. It is under investigation in clinical trial NCT01611805 (Japanese Phase I of GSK1605786).
Investigational
Matched Categories: … Sulfur Compounds …
2-(N-morpholino)ethanesulfonic acid
Experimental
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
1-Naphthylamine-5-sulfonic acid
Experimental
Matched Categories: … Sulfur Acids ... Sulfur Compounds …
Displaying drugs 501 - 525 of 1069 in total